Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, including the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use - and failure to do so may possibly be grounds for compensation. Our lawyers are working tough to get these hurt by the drug the compensation they are entitled to.

While bleeding can be a common complication associated with anticoagulants, it has been alleged that Xarelto is more harmful than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This means that, within the event of an emergency, sufferers could be at risk for irreversible bleeding difficulties, like life-threatening internal and gastrointestinal hemorrhaging.

Should you or a loved 1 suffered a serious bleeding event after taking Xarelto, you might have legal recourse. For far more data, contact us nowadays to have your case reviewed, totally free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenses. Additionally, they're seeking punitive damages, which are typically awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning side effects of xarelto blood thinner can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit this page for much more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
이 게시물을..